Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity.


Journal

Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 22 11 2018
medline: 14 6 2019
entrez: 22 11 2018
Statut: ppublish

Résumé

To compare the therapeutic effects of ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity. From August 2015 to April 2016, 60 patients with lower extremity deep venous thrombosis were randomly divided into two groups ( n = 30 for each) to receive catheter-directed thrombolysis. Group A was treated under the ultrasound guidance, while Group B was treated without guidance. Catheter-directed thrombolysis was successfully performed by only one intubate in Group A but by 5.9 intubates in Group B. It took 15.4 ± 3.2 min in Group A, significantly less than that in Group B (30.8 ± 6.6 min, p < 0.05). The incidences of hematoma were also remarkably different between the two groups (3.33% vs. 26.67%, p = 0.026). No pseudoaneurysm or arteriovenous fistula was found in Group A, but there were two cases of pseudoaneurysm and two cases of arteriovenous fistula in Group B (both 6.67%, p = 0.492). The circumference differences of the affected limb between before and after thrombolysis were 49.47 ± 2.484 mm in Group A, significantly higher than that in Group B (28.40 ± 2.856 mm, p < 0.001). After treatment, the venous unobstructed improvement rates and deep vein patency rate were both better than those in Group B (77 + 2.603% vs. 57.23 + 1.828% and 80% vs. 46.67%, respectively; p < 0.001). There were only three cases of PTS in Group A (10%, 3/30), but there were 11 cases in Group B (36.67%, 11/30). Ultrasound-guided catheter-directed thrombolysis has advantages, with improvement of venous patency and decrease of the incidence of PTS.

Identifiants

pubmed: 30458684
doi: 10.1177/1708538118814609
doi:

Substances chimiques

Fibrinolytic Agents 0
Urokinase-Type Plasminogen Activator EC 3.4.21.73

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-283

Auteurs

Chengyan Zhu (C)

1 Department of Surgical Ultrasound, The Affiliated Drum Tower Hospital to Medical School of Nanjing University, China.

Huawei Zhuo (H)

2 Department of Vascular Surgery, The Affiliated Drum Tower Hospital to Medical School of Nanjing University, China.

Yi Qin (Y)

2 Department of Vascular Surgery, The Affiliated Drum Tower Hospital to Medical School of Nanjing University, China.

Weiwei Zhang (W)

1 Department of Surgical Ultrasound, The Affiliated Drum Tower Hospital to Medical School of Nanjing University, China.

Junlan Qiu (J)

1 Department of Surgical Ultrasound, The Affiliated Drum Tower Hospital to Medical School of Nanjing University, China.

Feng Ran (F)

2 Department of Vascular Surgery, The Affiliated Drum Tower Hospital to Medical School of Nanjing University, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH